健赞

{{Infobox company
|name = 赛诺菲健赞
Sanofi Genzyme
|image=Genzyme building.jpg
|caption= 赛诺菲健赞总部，剑桥 (马萨诸塞州)
| logo = Genzyme logo.svg
| type = 全资子公司
| foundation = 波士顿 (1981)
| location_city = 马萨诸塞州剑桥
| location_country =
| key_people = David Meeker, MD
| industry = 生物技术
| products = Cerezyme
Fabrazyme
Synvisc
Renagel

| revenue = US $4.61 billion (2007 calendar)
| operating_income = US $581 million (2007 calendar)

收购出价
2010年8月30日，赛诺菲宣布以185亿美元收购健赞，该交易后来被其董事会拒绝。2011年2月16日，赛诺菲又以201亿美元全面收购健赞。

参考来源
外部链接

• Schouten, E. "Genzyme’s lifelong commitments". NRC Handelsblad. November 24, 2005.
• https://web.archive.org/web/20060924143610/http://www.gaucher.org.uk/cercer.htm
• Hirehealth’s website (https://web.archive.org/web/20061029102247/http://www.hirehealth.com/Public/CompanyDetails.aspx?COMPANY_ID=44719)
• Riskind. P. Multiple Sclerosis—The immune system’s terrible mistake. Fall 1996, Vo. 5, No. 4.
• Hoovers’ website (http://www.hoovers.com/genzyme/--ID__13560--/free-co-factsheet.xhtml )
• Calabro, S. "Genzyme put patients first, and grew to become a multi-billion-dollar company. But empires don't survive on altruism." Pharmaceutical Executive, [March 1, 2006] (http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=310976&&pageID=7&searchString=genzyme )

*[http://www.genzyme.com Genzyme corporate website]
*[http://www.opensecrets.org/lobby/clientsum.php?lname=Genzyme+Corp&year=2009 Center for Responsive Politics profile]